SEARCH

SEARCH BY CITATION

References

  • Borg, A., Yin, J.A., Johnson, P.R., Tosswill, J., Saunders, M., Morris, D. (1996) Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. British Journal of Haematology, 94, 713715.
  • Calvert, A.H., Harland, S.J., Newell, D.R., Siddik, Z.H., Jones, A.C., McElwain, T.J., Raju, S., Wiltshaw, E., Smith, I.E., Baker, J.M., Peckham, M.J., Harrap, K.R. (1982) Early clinical studies with cis- diammine-1, 1-cyclobutane dicarboxylate platinum II. Cancer Chemotherapy and Pharmacology, 9, 140147.
  • Calvert, A.H., Newell, D.R., Gumbrell, L.A., O'Reilly, S., Burnell, M., Boxall, F.E., Sussujm, Z.H., Judson, I.R., Gore, M.E., Wiltshaw, E. (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. Journal of Clinical Oncology, 7, 17481756.
  • Gill, P.S., Harrington, W., Kaplan, M.H., Ribeiro, R.C., Bennett, J.M., Liebman, H.A., Bernstein-Singer, M., Espina, B.M., Cabral, L., Allen, S., Kornblau, S., Pike, M.C., Levine, A.M. (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine, 332, 17441748.
  • Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., Cazals-Hatem, D., Bosly, A., Xerri, L., Tilly, H., Berger, F., Bouhabdallah, R., Diebold, J., for the Groupe d'Etudes des Lymphomes l'Adulte (GELA) (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood, 92, 7682.
  • Hermine, O., Bouscary, D., Gessain, A., Turlure, P., Leblond, V., Franck, N., Buzyn-Veil, A., Rio, B., Macintyre, E., Dreyfus, F., Bazarbachi, A. (1995) Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. New England Journal of Medicine, 332, 17491751.
  • Hodozuka, A., Sako, K., Nakai, H., Tomabechi, M., Suzuki, N., Yonemasu, Y. (1993) Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus venous infusion. Journal of Neurooncology, 15, 7986.
  • Ikeda, K., Oka, M., Yamada, Y., Soda, H., Fukuda, M., Kinoshita, A., Tsukamoto, K., Noguchi, Y., Isomoto, H., Takeshima, F., Murase, K., Kamihira, S., Tomonaga, M., Kohno, S. (1999) Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung- resistance-protein (LRP) genes. International Journal of Cancer, 82, 599604.
  • Kalbfleish, J.D. & Prentice, R.L. (1980) The statistical analysis of failure time data. New York, NY. John Wiley & Sons, Inc.
  • Kleiner, S., Kirsch, A., Schwaner, I., Kingreen, D., Schwella, N., Huhn, D. (1997) High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study. Bone Marrow Transplantation, 20, 953959.
  • Kuwazuru, Y., Hanada, S., Furukawa, T., Yoshimura, A., Sumizawa, T., Utsunomiya, A., Ishibashi, T., Saito, T., Uozumi, K., Maruyama, M. (1990) Expression of P-glycoprotein in adult T-cell leukemia cells. Blood, 76, 20652071.
  • Lymphoma Study Group (1982) Final results of cooperative study of VEPA [vincristine, cyclophosphamide (Endoxan), prednisolone and adriamycin] therapy in advanced adult non-Hodgkin's lymphoma: Relation between T- or B-cell phenotype and response. Japanese Journal of Clinical Oncology, 12, 227238.
  • Matsuoka, T., Kimura, K., Miyazaki, T. & 48 Others (1983) Phase II study with methyl-6 [[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy- alpha-d-glucopyranoside (MCNU) in hematological malignancies. Gan to Kagaku Ryoho [in Japanese], 10, 15181523.
  • Naito, K., Kobayashi, M., Oyama, A., Kodera, Y., Tanaka, M., Kamiya, O., Mitomo, Y., Ohno, R., Sampi, K., Hirano, M., Shirakawa, S., Yamada, K., Kimura, K. (1988) Phase II study of carboplatin in malignant lymphoma. Gan to Kagaku Ryoho [in Japanese], 15, 21452151.
  • Ohno, R., Masaoka, T., Shirakawa, S., Sakamoto, S., Hirano, M., Hanada, S., Yasunaga, K., Yokomaku, S., Mitomo, Y., Nagai, K., Yamada, K., Furue, H., for the MST-16 Study Group. (1993) Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis (2,6-dioxopiperazine). Cancer, 71, 22172221.
  • Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649655.
  • Sekido, S., Ninomiya, K., Iwasaki, M. (1979) Biologic activity of MCNU: a new antitumor agent. Cancer Treatment Reports, 63, 961970.
  • Shimoyama, M. (1992) Treatment of patients with adult T-cell leukemia-lymphoma: an overview. In: Advances in Adult T-Cell Leukemia and HTLV-I Research Gann. Monograph on Cancer Research No 39 (ed. by K.Takatsuki, Y.Hinuma & M. Yoshida), p4356. Japan Scientific Societies Press, Tokyo, Japan.
  • Shimoyama, M. (1994) Chemotherapy of ATL. In: Adult T-Cell Leukemia (ed.by K.Takatsuki), p221237. Oxford University Press, Oxford, UK.
  • Shimoyama, M., Ota, K., Kikuchi, M., Yunoki, K., Konda, S., Takatsuki, K., Ichimaru, M., Ogawa, M., Kimura, I., Tominaga, S., Tsugane, S., Taguchi, H., Minato, K., Takenaka, T., Tobinai, K., Kurita, S., Oyama, A., Hisano S., Kozuru, M., Matsumoto, M., Nomura, K., Takiguchi, T., Sugai, S., Yamaguchi, K., Hattori, T., Kinoshita, K., Tajima, K., Suemasu, K., for the Lymphoma Study Group. (1981–83) (1988a) Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. Journal of Clinical Oncology, 6, 128141.
  • Shimoyama, M., Ota, K., Kikuchi, M., Yunoki, K., Konda, S., Takatsuki, K., Ichimaru, M., Tominaga, S., Tsugane, S., Minato, K., Tobinai, K., Oyama, A., Hisano, S., Matsumoto, M., Takiguchi, T., Yamaguchi, K., Kinoshita, K., Tajima, K., Suemasu, K., for the Lymphoma Study Group. (1981–83) (1988b) Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. Journal of Clinical Oncology, 6, 10881097.
  • Shimoyama, M. & Members of The Lymphoma Study Group (1984–87) (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from The Lymphoma Study Group (1984–87). British Journal of Haematology, 79, 428437.
  • Sobue, R., Yamauchi, T., Miyamura, K., Sao, H., Tahara, T., Yoshikawa, H., Yoshikawa, S., Morishima, Y., Kodera, Y. (1987) Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplantation, 2, 441444.
  • Taguchi, H., Kinoshita, K., Takatsuki, K., Tomonaga, M., Araki, K., Arima, N., Ikeda, S., Uozumi, K., Kohno, H., Kawano, F., Kikuchi, H., Takahashi, H., Tamura, K., Chiyoda, S., Tsuda, H., Nishimura, H., Hosokawa, T., Matsuzaki, H., Momita, S., Yamada, O., Miyoshi, I. (1996) An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 182186.
  • Tajima, K., For The T- and B-cell Malignancy Study Group, . (1990) The fourth nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. International Journal of Cancer, 45, 237243.
  • The, T- and B-cell Malignancy Study Group (1988) The third nationwide study on adult T-cell leukemia/lymphoma (ATL) in Japan: Characteristic patterns of HLA antigen and HTLV-I infection in ATL patients and their relatives. International Journal of Cancer, 41, 505512.
  • Tobinai, K., Shimoyama, M., Inoue, S., Takayasu, S., Mikuni, C., Kozuru, M., Oda, S., Nakajima, H. & members of the DCF Study Group. (1992) Phase I study of YK-176 (2-Deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. Japanese Journal of Clinical Oncology, 22, 164171.
  • Tobinai, K., Kohno, A., Shimada, Y., Watanabe, T., Tamura, T., Takeyama, K., Narabayashi, M., Fukutomi, T., Kondo, H., Shimoyama, M. (1993) Toxicity grading criteria of the Japan Clinical Oncology Group. The clinical trial review committee of the Japan Clinical Oncology Group. Japanese Journal of Clinical Oncology, 23, 250257.
  • Tobinai, K., Shimoyama, M., Minato, K., Shirakawa, S., Hotta, T., Furuhara, S., Suzuki, H., Ichimaru, M., Sai, T., Konda, S., Mikuni, D., Toki, H., Kozuru, M., Deura, K., Takatsuki, K., For The Lymphoma Study Group, J.C.O.G. (1987–91) (1994) Japan Clinical Oncology Group (JCOG) trial of second-generation ‘LSG4 protocol’ in aggressive lymphoma including ATL: Prognostic factors and a predictive model (Abstract). Proceedings of the American Society of Clinical Oncology, 13, 378.
  • Tobinai, K., Shimoyama, M., Tajima, K., Kozuru, M., Tomonaga, M., Araki, K., Kasai, M., Takatsuki, K., Tara, M., Hotta, T., Mikuni, C. & members of the 30 institutions for the JCOG-Lymphoma Study Group. (1995) Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group (JCOG) Study #9109 (Abstract). Proceedings of the American Society of Clinical Oncology, 14, 390.
  • Tsuda, H., Takatsuki, K., Ohno, R., Masaoka, T., Okada, K., Shirakawa, S., Ohashi, Y., Ota, K. & the CPT-11 Study Group on Hematological Malignancy, Tokyo, Japan. (1994) Treatment of adult T-cell leukaemia- lymphoma with irinotecan hydrochloride (CPT11). British Journal of Cancer, 70, 771774.
  • Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., Uchino, H. (1977) Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood, 50, 481492.
  • Utsunomiya, A., Miyazaki, Y., Takatsuka, Y., Hanada, S., Uozumi, K., Yashiki, S., Tara, M., Kawano, F., Saburi, Y., Kikuchi, H., Hara, M., Sao, H., Morishima, Y., Kodera, S., Sonoda, S., Tomonaga, M. (2001) Improved outcome of adult, T-cell leukemia/lymphoma by allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 27, 1520.
  • Waldmann, T.A., White, J.D., Goldman, C.K., Top, L., Grant, A., Bamford, R., Roessler, E., Horak, I.D., Zaknoen, S., Kasten-Sportes, C., England, R., Horak, E., Mishra, B., Dipre, M., Hale, P., Fleisher, T.A., Junghans, R.P., Jaffe, E.S., Nelson, D.L. (1993) The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I- induced adult T-cell leukemia. Blood, 82, 17011712.
  • Walker, M.D. & Hilton, J. (1976) Nitrosourea pharmacodynamics in relation to the central nervous system. Cancer Treatment Reports, 60, 725728.
  • Yamada, Y., Kamihira, S., Amagasaki, T., Kinoshita, K., Kusano, M., Chiyoda, S., Yawo, E., Ikeda, S., Suzuyama, J., Ichimaru, M. (1985) Adult T-cell leukemia with atypical surface phenotypes: Clinical correlation. Journal of Clinical Oncology, 3, 782788.